(3S)-(-)-3-(tert-Butoxycarbonylamino)pyrrolidine>98.0%(GC)(T)5g

4-Bromo-6-methoxyisoindolin-1-one, 95+%, 250mg

2-(2-(Bromomethyl)phenyl)acetonitrile, 97.0%, 1g

tert-butyl 4-[2-(4-methoxyphenyl)-2-oxoethyl]piperazine-1-carboxylate, 95.0%, 10g

2-(4-Methylpiperazin-1-yl)benzonitrile, 95.0%, 5g

HPLC-Anschluss-Kappe GL 45, mit 3 Gewindeanschlüssen, 1 Stück

2H-Imidazo[4,5-c]quinolin-2-one, 8-[6-[3-(dimethylamino)propoxy]-3-pyridinyl]-1,3-dihydro-3-methyl-1-(tetrahydro-2H-pyran-4-yl)-, 25mg

4-Difluoromethoxy-3-ethoxy-phenylamine, 1g

(2-BROMO-4-METHYLPHENYL)(2-CHLORO-4-FLUOROPHENYL)METHANONE, 95%, 10g

Dimethyl 2-hydroxysuccinate, 97%, 10g

4-Methoxypyrimidine-5-carbaldehyde, 97%, 100mg

5-Bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine, 97.0%, 100mg

TERT-BUTYL 4-AMINO-2-FLUOROBENZOATE, 95.0%, 1g